Visfatin plays a significant role in obesity‐associated metabolic and inflammatory disorders, and most studies have reported elevated plasma or tissue levels in obese rats (Nanda et al. 2024; Sun et al. 2012). This evidence concerns the gene NAMPT and obesity disorder.